NCI-MATCH launch highlights new trial design in precision-medicine era

MeSH terms

• Antineoplastic Agents* / pharmacology
• Antineoplastic Agents* / therapeutic use
• Clinical Trials as Topic* / methods
• Clinical Trials as Topic* / standards
• Clinical Trials as Topic* / trends
• DNA, Neoplasm / analysis
• Genetic Testing
• Humans
• Mass Screening
• Molecular Targeted Therapy* / methods
• Molecular Targeted Therapy* / trends
• Mutation*
• National Cancer Institute (U.S.)
• Neoplasms / drug therapy*
• Neoplasms / genetics*
• Precision Medicine* / methods
• Precision Medicine* / trends
• Research Design* / standards
• Research Design* / trends
• Sequence Analysis, DNA
• United States